Prothena Corp Public (PRTA) Short-term Investments (2019 - 2024)

Prothena Corp Public (PRTA) recorded quarterly Short-term Investments of $1.4 million in Q1 2024, little changed quarter-over-quarter from $1.4 million in Q4 2023.

Prothena Corp Public (PRTA) Short-term Investments (2019 - 2024) Analysis & Trends

Prothena Corp Public's Short-term Investments history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2024.

  • In Q1 2024, Short-term Investments changed N/A year-over-year to $1.4 million; the TTM figure through Mar 2024 stood at $1.4 million (changed N/A YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
  • Short-term Investments was $1.4 million for Q1 2024 at Prothena Corp Public, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.4 million in Q3 2020 to a low of $1.4 million in Q3 2020.
  • Historically, Short-term Investments has averaged $1.4 million across 4 years, with a median of $1.4 million in 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Prothena Corp Public 479.08 Mn 149.61 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 1.35 Mn
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 1.35 Mn
Jun 30, 2021 1.35 Mn
Mar 31, 2021 1.35 Mn
Dec 31, 2020 1.35 Mn
Sep 30, 2020 1.35 Mn
Jun 30, 2019 1.35 Mn
Mar 31, 2019 1.35 Mn